Inogen Inc.
Nasdaq INGN · Beverly, MA
Works in Cardiovascular · Infectious disease · Respiratory
Inogen Inc. is a clinical trial sponsor based in Beverly, MA, listed as Nasdaq INGN. It has 1 active clinical trial with 35 planned participants, in Cardiovascular, Infectious disease and Respiratory. Since 2021 it has completed 4 trials and stopped 0 early.
Trial track record · since 2021
Financials · Nasdaq INGN
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Inogen Inc
Inogen Inc is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 35 planned participants, in Cardiovascular, Infectious disease, Respiratory. Since 2021 it has completed 4 trials and stopped 0 early.
Inogen Inc is based in Beverly, MA and is listed as Nasdaq INGN. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Inogen Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-03-02.
Approve Suite is not affiliated with Inogen Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.